e.g. Tata motors, Reliance MF, 500570

Aarti Pharmalabs Ltd. - Research Center

543748 AARTIPHARM Group (A) BSE data
 
Back to Company Page
Statement:

Profit loss account

(Rs crore)
Mar ' 24 Mar ' 23 Mar ' 22 Mar ' 21
Income
Operating income 1,502.13 1,511.25 941.02 -
Expenses
Material consumed 751.97 759.17 491.80 -
Manufacturing expenses 82.92 282.54 167.97 -
Personnel expenses 130.33 122.16 79.98 -
Selling expenses 6.40 5.13 0.31 -
Adminstrative expenses 184.35 33.92 21.16 -
Expenses capitalised - - - -
Cost of sales 1,155.97 1,202.91 761.24 -
Operating profit 346.16 308.34 179.79 -
Other recurring income 11.01 1.28 2.51 -
Adjusted PBDIT 357.17 309.62 182.30 -
Financial expenses 16.63 20.49 11.34 -
Depreciation 66.01 55.77 37.23 -
Other write offs - - - -
Adjusted PBT 274.52 233.36 133.73 -
Tax charges 73.87 61.63 27.00 -
Adjusted PAT 200.65 171.73 106.73 -
Non recurring items - - - -
Other non cash adjustments - - - -
Reported net profit 200.65 171.73 106.73 -
Earnigs before appropriation 1,060.19 877.67 705.95 -0.02
Equity dividend 18.13 18.13 - -
Preference dividend - - - -
Dividend tax - - - -
Retained earnings 1,042.07 859.55 705.95 -0.02
Close
Add Aarti Pharmalabs Ltd. to your Portfolio
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add Aarti Pharmalabs Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close

Home

Market News

Latest News

International Markets

Economy

Industries

Mutual Fund News

IPO News

Search News

My Portfolio

My Watchlist

Gainers

Losers

Sectors

Indices

Forex

Mutual Funds

Feedback